The role of fluorine-18-fluorodeoxyglucose positron emission tomography in evaluating the response to tyrosine-kinase inhibitors in patients with metastatic primary renal cell carcinoma. Radiol Oncol [Internet]. 2014 Aug. 27 [cited 2026 Oct. 25];48(3). Available from: https://www.radioloncol.com/index.php/ro/article/view/1550